Annexin A2 Expression in Head and Neck Squamous Cell Carcinoma

[1]  C. Nieto,et al.  Expresión de las anexinas a1 y a2 en la mucosa del tracto aerodigestivo superior , 2004 .

[2]  Zhihua Liu,et al.  The deregulation of arachidonic acid metabolism‐related genes in human esophageal squamous cell carcinoma , 2003, International journal of cancer.

[3]  Maria D Person,et al.  Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration , 2003, Oncogene.

[4]  A. Herrero,et al.  Expression of E-cadherin in squamous cell carcinomas of the supraglottic larynx with correlations to clinicopathological features. , 2002, European journal of cancer.

[5]  S. Moss,et al.  Annexins: from structure to function. , 2002, Physiological reviews.

[6]  Y. Nakajima,et al.  Annexin II overexpression correlates with stromal tenascin‐C overexpression , 2001, Cancer.

[7]  Y. Nakajima,et al.  Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma. , 2001, Anticancer research.

[8]  H. Aburatani,et al.  Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. , 2001, Cancer research.

[9]  Bonnie F. Sloane,et al.  Cell surface complex of cathepsin B/annexin II tetramer in malignant progression. , 2000, Biochimica et biophysica acta.

[10]  Christian A. Rees,et al.  Systematic variation in gene expression patterns in human cancer cell lines , 2000, Nature Genetics.

[11]  M. McLaughlin,et al.  Annexin II and bleeding in acute promyelocytic leukemia. , 1999, The New England journal of medicine.

[12]  S. Pileri,et al.  The EnVision++ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. , 1998, Journal of clinical pathology.

[13]  F. Real,et al.  The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro , 1998, Oncogene.

[14]  I Vergote,et al.  A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Cooperative Group. , 1997, Journal of clinical pathology.

[15]  J. Vishwanatha,et al.  Altered expression of annexin II in human B-cell lymphoma cell lines. , 1996, Biochimica et biophysica acta.

[16]  J. Califano,et al.  11:40 AM: A Genetic Progression Model for Head and Neck Cancer: Implications for Field Cancerization , 1996 .

[17]  D. Waisman.  Annexin II tetramer: structure and function , 1995, Molecular and Cellular Biochemistry.

[18]  K. Koretz,et al.  Differential expression of annexins I and II in normal and malignant human mammary epithelial cells. , 1993, Differentiation; research in biological diversity.

[19]  M. Pinkoski,et al.  Elevated expression of annexin II (lipocortin II, p36) in a multidrug resistant small cell lung cancer cell line. , 1992, British Journal of Cancer.

[20]  J. Wands,et al.  Enhanced expression of the protein kinase substrate p36 in human hepatocellular carcinoma. , 1990, Molecular and cellular biology.

[21]  Li Mao,et al.  Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry , 2004, Clinical & Experimental Metastasis.

[22]  R. O. Morgan,et al.  Structure, Function and Evolution of the Annexin Gene Superfamily , 2003 .

[23]  Wei Xin,et al.  Dysregulation of the annexin family protein family is associated with prostate cancer progression. , 2003, The American journal of pathology.

[24]  M. Israel,et al.  Annexin II marks astrocytic brain tumors of high histologic grade. , 1994, Oncology research.